Case report| Volume 65, ISSUE 9, P1259-1261, September 2012

Successful treatment of cutaneous zygomycosis with extensive surgical debridement and oral posaconazole in an immunocompetent patient

Published:March 05, 2012DOI:


      We describe a case of successful treatment of cutaneous zygomycosis using a combination of extensive surgical debridement and the oral antifungal agent, posaconazole.


      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Journal of Plastic, Reconstructive & Aesthetic Surgery
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Spellberg B.
        • Edwards Jr., J.
        • Ibrahim A.
        Novel perspectives on mucormycosis: pathophysiology, presentation, and management.
        Clin Microbiol Rev. 2005; 18: 556-569
        • Roden M.M.
        • Zaoutis T.E.
        • Buchanan W.Z.
        • et al.
        Epidemiology and outcome of zygomycosis: a review of 929 reported cases.
        Clin Infect Dis. 2005; 41: 634-653
        • Ledgard J.P.
        • van Hal S.
        • Greenwood J.E.
        Primary cutaneous zygomycosis in a burns patient: a review.
        J Burn Care Res. 2008; 29: 286-290
        • Patino J.F.
        Necrotizing soft tissue lesions after a volcanic cataclysm.
        World J Surg. 1991; 15: 240-247
        • Andresen D.
        Multifocal cutaneous mucormycosis complicating polymicrobial wound infections in a tsunami survivor from Sri Lanka.
        Lancet. 2005; 365: 876-878
        • Walsh T.J.
        Infections due to emerging and uncommon medically important fungal pathogens.
        Clin Microbiol Infect. 2004; 10: 48-66
        • Tarrand J.J.
        • Lichterfeld M.
        • Warraich I.
        • et al.
        Diagnosis of invasive septate mold infections. a correlation microbiological culture histologic or cytologic examination.
        Am J Clin Pathol. 2003; 119: 854-858
        • Arnaiz-Garcıa M.E.
        • Alonso-Peña D.
        • González-Vela Mdel C.
        • et al.
        Cutaneous mucormycosis: report of five cases and review of the literature.
        J Plast Reconstr Aesthet Surg. 2009; 62: e434-e441
        • Sugar A.M.
        Agents of mucormycosis and related species.
        in: Mandell G.L. Principles and practice of infectious diseases. Elsevier, 2000: 2973-2984
        • Greenberg R.N.
        • Scott L.J.
        • Vaugh H.H.
        • et al.
        Zygomycosis (mucormycosis): emerging clinical importance and new treatments.
        Curr Opin Infect Dis. 2004; 17: 517-525
        • Herbrecht R.
        Posaconazole: a potent, extended-spectrum triazole anti-fungal for the treatment of serious fungal infections.
        Int J Clin Pract. 2004; 58: 612-624